Publication | Closed Access

Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1β and interleukin-1 receptor antagonist and pregnancy outcome

InflammationMaternal ImmunizationInterleukin-1 Receptor AntagonistReproductive HealthImmunologyGynecologyMaternal HealthPregnancyIntron 2Fetal MedicineAmniotic Fluid ConcentrationsMaternal-fetal MedicinePublic HealthFetal ComplicationMedicinePreeclampsia